Terms: = Uterine cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Diagnosis
68 results:
1. Uptake and barriers to cervical cancer screening among human immunodeficiency virus-positive women in Sub Saharan Africa: a systematic review and meta-analysis.
Mengesha MB; Chekole TT; Hidru HD
BMC Womens Health; 2023 Jun; 23(1):338. PubMed ID: 37370091
[TBL] [Abstract] [Full Text] [Related]
2. Risk Factors for Major Complications Following Minimally Invasive Surgeries for Endometriosis in the United States.
Meyer R; Siedhoff M; Truong M; Hamilton K; Fan S; Levin G; Barnajian M; Nasseri Y; Wright K
J Minim Invasive Gynecol; 2023 Oct; 30(10):820-826. PubMed ID: 37321298
[TBL] [Abstract] [Full Text] [Related]
3. Implementing universal upfront multi-gene panel testing in endometrial cancer: From cost to practical considerations.
Levine MD; Barrington DA; Hampel H; Goodfellow PJ; Cohn DE
Gynecol Oncol; 2022 Sep; 166(3):538-542. PubMed ID: 35871048
[TBL] [Abstract] [Full Text] [Related]
4. Unexpected actionable genetic variants revealed by multigene panel testing of patients with uterine cancer.
Heald B; Mokhtary S; Nielsen SM; Rojahn S; Yang S; Michalski ST; Esplin ED
Gynecol Oncol; 2022 Aug; 166(2):344-350. PubMed ID: 35691755
[TBL] [Abstract] [Full Text] [Related]
5. Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer.
Minoura Y; Takahashi M; Maeda H; Kuwahara S; Tachikawa H; Yamamoto M; Tomioka N; Watanabe K; Sakurai A
Breast Cancer; 2022 Sep; 29(5):808-813. PubMed ID: 35641852
[TBL] [Abstract] [Full Text] [Related]
6. Protocol for the Detection of Organoid-Initiating Cell Activity in Patient-Derived Single Fallopian Tube Epithelial Cells.
Feng L; Yang W; Zhao H; Bakkum-Gamez J; Sherman ME; Kannan N
Methods Mol Biol; 2022; 2429():445-454. PubMed ID: 35507180
[TBL] [Abstract] [Full Text] [Related]
7. Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical cancer.
Reza MS; Harun-Or-Roshid M; Islam MA; Hossen MA; Hossain MT; Feng S; Xi W; Mollah MNH; Wei Y
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409328
[TBL] [Abstract] [Full Text] [Related]
8. Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements.
Tsai JW; Lee JC; Hsieh TH; Huang SC; Lee PH; Liu TT; Kao YC; Chang CD; Weng TF; Li CF; Lin JC; Liang CW; Su YL; Chang IY; Wang YT; Chang NY; Yu SC; Wang JC; Huang HY
Mod Pathol; 2022 Jul; 35(7):911-921. PubMed ID: 35149769
[TBL] [Abstract] [Full Text] [Related]
9. Prevalence and clinical characterization of brca1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer.
Paik ES; Heo EJ; Choi CH; Kim JH; Kim JW; Kim YM; Park SY; Lee JW; Kim JW; Kim BG
Cancer Sci; 2021 Dec; 112(12):5055-5067. PubMed ID: 34657357
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological characterization of a real-world multicenter cohort of endometrioid ovarian carcinoma: Analysis of the French national ESME-Unicancer database.
De Nonneville A; Zemmour C; Frank S; Joly F; Ray-Coquard I; Costaz H; Classe JM; Floquet A; De la Motte Rouge T; Colombo PE; Sauterey B; Leblanc E; Pomel C; Marchal F; Barranger E; Savoye AM; Guillemet C; Petit T; Pautier P; Rouzier R; Gladieff L; Simon G; Courtinard C; Sabatier R
Gynecol Oncol; 2021 Oct; 163(1):64-71. PubMed ID: 34294414
[TBL] [Abstract] [Full Text] [Related]
11. Case-case analysis addressing ascertainment bias for multigene panel testing implicates brca1 and PALB2 in endometrial cancer.
Johnatty SE; Pesaran T; Dolinsky J; Yussuf A; LaDuca H; James PA; O'Mara TA; Spurdle AB
Hum Mutat; 2021 Oct; 42(10):1265-1278. PubMed ID: 34245638
[TBL] [Abstract] [Full Text] [Related]
12. Endometrial cancer, brca1, and BRCA2 in the UK Biobank Cohort.
Lehrer S; Rheinstein PH
Am J Clin Oncol; 2021 Jul; 44(7):299-300. PubMed ID: 34008499
[TBL] [Abstract] [Full Text] [Related]
13. Endometrial cancer Risk in Women With Germline brca1 or BRCA2 Mutations: Multicenter Cohort Study.
de Jonge MM; de Kroon CD; Jenner DJ; Oosting J; de Hullu JA; Mourits MJE; Gómez Garcia EB; Ausems MGEM; Margriet Collée J; van Engelen K; van de Beek I; ; Smit VTHBM; Rookus MA; de Bock GH; van Leeuwen FE; Bosse T; Dekkers OM; van Asperen CJ
J Natl Cancer Inst; 2021 Sep; 113(9):1203-1211. PubMed ID: 33710348
[TBL] [Abstract] [Full Text] [Related]
14. Successful treatment of a patient with brain metastases from endometrial cancer using Niraparib: a case report.
Wang Q; Zhang F; Gao H; Xu Y
Ann Palliat Med; 2021 Jan; 10(1):818-827. PubMed ID: 33545804
[TBL] [Abstract] [Full Text] [Related]
15. Hereditary leiomyomatosis and renal cell carcinoma: a case series and literature review.
Chayed Z; Kristensen LK; Ousager LB; Rønlund K; Bygum A
Orphanet J Rare Dis; 2021 Jan; 16(1):34. PubMed ID: 33461594
[TBL] [Abstract] [Full Text] [Related]
16. Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers.
Evans DG; Lalloo F; Ryan NA; Bowers N; Green K; Woodward ER; Clancy T; Bolton J; McVey RJ; Wallace AJ; Newton K; Hill J; McMahon R; Crosbie EJ
J Med Genet; 2022 Apr; 59(4):328-334. PubMed ID: 33452216
[TBL] [Abstract] [Full Text] [Related]
17. A population-based study of causes of death after endometrial cancer according to major risk factors.
Lees B; Hampton JM; Trentham-Dietz A; Newcomb P; Spencer R
Gynecol Oncol; 2021 Mar; 160(3):655-659. PubMed ID: 33422300
[TBL] [Abstract] [Full Text] [Related]
18. Universal screening for Lynch syndrome in uterine cancer patients: A quality improvement initiative.
Spinosa D; Acosta T; Wong J; Kurtovic K; Mewshaw J; Collins S; Kauff N; Havrilesky LJ; Strickland KC; Previs RA
Gynecol Oncol; 2021 Jan; 160(1):169-174. PubMed ID: 33393478
[TBL] [Abstract] [Full Text] [Related]
19. Should the risk for uterine cancer influence decision making for prophylactic hysterectomy in brca1/2 mutated patients- a systematic review and meta-analysis.
Nahshon C; Segev Y; Gemer O; Bar Noy T; Schmidt M; Ostrovsky L; Lavie O
Gynecol Oncol; 2021 Mar; 160(3):755-762. PubMed ID: 33309051
[TBL] [Abstract] [Full Text] [Related]
20. Prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers: what is going on in a region of northern Italy?
Grandi G; Perrone AM; Perrone A; Mandato VD; Comerci G; Sammarini M; Merisio C; Amadori A; Stefanetti M; Martinello R; Facchinetti F; De Iaco P;
Maturitas; 2021 Jan; 143():59-64. PubMed ID: 33308637
[TBL] [Abstract] [Full Text] [Related]
[Next]
